Edwards Lifesciences Corporation (EW) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:23 ET. Consensus EPS estimate is $0.73.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-23 | FY2026 Q2 | $0.74 | $0.78 | +5.0% | $1.74B |
| 2026-05-06 | FY2026 Q1 | $0.73 | $0.66 | -9.5% | $1.65B |
| 2025-11-05 | FY2025 Q3 | $0.60 | $0.50 | -16.1% | $1.55B |
| 2025-08-06 | FY2025 Q2 | $0.62 | $0.57 | -8.7% | $1.53B |
| 2025-05-06 | FY2025 Q1 | $0.60 | $0.61 | +2.3% | $1.41B |
| 2025-02-28 | FY2024 Q4 | $0.55 | $0.65 | +18.0% | $1.39B |
| 2024-07-31 | FY2024 Q2 | $0.69 | $0.61 | -11.6% | $1.39B |
| 2024-04-29 | FY2024 Q1 | $0.64 | $0.58 | -9.4% | $1.33B |
EW has beaten consensus EPS in 3 of its last 8 reported quarters.
See EW on the live calendar →